
Voglia GM 2mg/500mg/0.2mg Tablet ER
Marketer
Curis Lifecare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglia GM 2mg/500mg/0.2mg Tablet ER
Diabexa Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexa Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar; discontinuation without medical consultation risks hyperglycemia and potential complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly influence diabetes control. The most frequent adverse effect is hypoglycemia. Familiarize yourself with hypoglycemic symptoms (sweating, lightheadedness, headache, tremors) and appropriate countermeasures. Maintaining regular mealtimes and carrying a readily available fast-acting glucose source (e.g., sugary snacks, juice) is essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Voglia GM 2mg/500mg/0.2mg Tablet ER
Managing type 2 diabetes
Major Benefits of Voglia GM 2mg/500mg/0.2mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Voglia GM 2mg/500mg/0.2mg Extended-Release Tablet should be consumed on an empty stomach.
Common Side effects of Voglia GM 2mg/500mg/0.2mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglia GM 2mg/500mg/0.2mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Voglia GM 2mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
How Voglia GM 2mg/500mg/0.2mg Tablet ER works:
Each Voglia GM extended-release tablet (2mg/500mg/0.2mg) contains a triple-drug antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Voglia GM 2mg/500mg/0.2mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Voglia GM 2mg/500mg/0.2mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglia GM tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Voglia GM 2mg/500mg/0.2mg Extended-Release tablets in individuals with kidney impairment carries a high risk and is best avoided. Medical advice is crucial. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglia GM 2mg/500mg/0.2mg Extended-Release tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation at a reduced dose is typical; however, the medication is contraindicated in those with severe liver disease.
What if you forget to take Voglia GM 2mg/500mg/0.2mg Tablet ER :
Should you forget a dose of Voglia GM 2mg/500mg/0.2mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglia GM 2mg/500mg/0.2mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
